![]() | MERK - Merck Tbk. | MERK - Merck Tbk. | MERK - Merck Tbk. | |
Sector | : | Healthcare | ||
Sub Sector | : | Pharmaceuticals and Health Care Research | ||
Industry | : | Pharmaceuticals | ||
Sub Industry | : | Pharmaceuticals | ||
Index (5) | : | COMPOSITE, IDXHEALTH, ISSI, IDXSMC-COM, DBX | ||
Index (5) | : | COMPOSITE, IDXHEALTH, ISSI, IDXSMC-COM, DBX | ||
Board | : | 5 Index COMPOSITE, IDXHEALTH, ISSI, IDXSMC-COM, DBX | ||
Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
Pre Opening | : | Saham dapat diperdagangan melalui sesi Pre-opening | ||
Corporate Action | : | - | ||
RATING & BTO MATRIX | ||||||
---|---|---|---|---|---|---|
Benchmark to Others : | ||||||
A Exceptional | ||||||
B Excellent | ||||||
C Very Good | ||||||
D Good | ||||||
E Fair | ||||||
F Poor | ![]() |
|||||
RATING | ||||||
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING FUNDAMENTAL | ||
---|---|---|
Rating EPS | 3 | |
Rating ROA | 1 | |
Rating EQUITY | 1 | |
Rating ROE | 1 | |
Rating DER | 5 | |
Rating TOTAL | 2 |
MARKET CAPITALIZATION | ||
Listed Share | 448.000.000 | |
Price | Rp. 3.460 | |
Capitalization | Rp. 1.550.080.000.000 | |
OWNERSHIP | ||
Listing Date : | ||
Lokal 8,63 % | Asing 16,53 % | Lainnya 74,84 % |
![]() | MERK - Merck Tbk. | MERK - Merck Tbk. | MERK - Merck Tbk. | |
Sector | : | Healthcare | ||
Sub Sector | : | Pharmaceuticals and Health Care Research | ||
Industry | : | Pharmaceuticals | ||
Sub Industry | : | Pharmaceuticals | ||
Index (5) | : | COMPOSITE, IDXHEALTH, ISSI, IDXSMC-COM, DBX | ||
Index (5) | : | COMPOSITE, IDXHEALTH, ISSI, IDXSMC-COM, DBX | ||
Board | : | 5 Index COMPOSITE, IDXHEALTH, ISSI, IDXSMC-COM, DBX | ||
Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
Pre Opening | : | Saham dapat diperdagangan melalui sesi Pre-opening | ||
Corporate Action | : | - | ||
Description | 3Q18 | 3Q19 | 3Q20 | 3Q21 | 3Q22 | 3Q23 | 3Q24 | CAGR 5Y(%) |
Last Price | 5700 | 2810 | 2910 | 3290 | 5000 | 4720 | 3630 | |
Market Cap | 2.6 T | 1.3 T | 1.3 T | 1.5 T | 2.2 T | 2.1 T | 1.6 T | 23.08 |
BALANCE SHEET | ||||||||
Cash | 61.6 B | 83.3 B | 69.7 B | 217.3 B | 109.8 B | 169.8 B | 76.7 B | -7.92 |
Total Asset | 887.9 B | 800.9 B | 931.7 B | 925.0 B | 950.8 B | 927.7 B | 916.9 B | 14.48 |
S.T.Borrowing | 196.0 B | 224.0 B | 298.9 B | 193.2 B | 174.0 B | 140.7 B | 147.7 B | |
L.T.Borrowing | 54.6 B | 41.5 B | 35.0 B | 56.0 B | 50.5 B | 42.8 B | 39.6 B | |
Total Equity | 637.3 B | 535.3 B | 597.9 B | 675.8 B | 726.3 B | 744.3 B | 729.6 B | 36.30 |
INCOME STATEMENT | ||||||||
Revenue | 460.8 B | 498.0 B | 439.8 B | 786.1 B | 869.2 B | 780.6 B | 753.7 B | 51.35 |
Gross Profit | 187.1 B | 174.7 B | 199.6 B | 290.7 B | 325.6 B | 315.3 B | 241.0 B | 37.95 |
Operating Profit | 76.0 B | 30.7 B | 74.8 B | 155.2 B | 193.9 B | 171.3 B | 97.1 B | 216.29 |
Net.Profit | 138.4 B | 17.1 B | 55.1 B | 117.8 B | 149.7 B | 130.4 B | 77.1 B | 350.88 |
EBITDA | 76.8 B | 32.8 B | 84.3 B | 163.4 B | 202.3 B | 179.1 B | 105.2 B | 220.73 |
Interest Expense | 650.2 M | 4.0 B | 2.9 B | 1.1 B | 2.3 B | 2.8 B | 2.9 B | |
RATIO | ||||||||
EPS | 308.86 | 38.1 | 122.92 | 262.92 | 334.26 | 291.05 | 172 | 351.44 |
PER | 18.45 x | 73.75 x | 23.67 x | 12.51 x | 14.96 x | 16.22 x | 21.10 x | |
BVPS | 1422.61 | 1194.98 | 1334.53 | 1508.52 | 1621.14 | 1661.32 | 1628.52 | |
PBV | 4.01 x | 2.35 x | 2.18 x | 2.18 x | 3.08 x | 2.84 x | 2.23 x | |
ROA | 0.1558 | 0.0213 | 0.0591 | 0.1273 | 0.1575 | 0.1405 | 0.084 | 294.37 |
ROE | 0.2171 | 0.0319 | 0.0921 | 0.1743 | 0.2062 | 0.1752 | 0.1056 | 231.03 |
EV/EBITDA | 35.69 | 44 | 18.59 | 9.22 | 11.64 | 11.88 | 16.51 | |
Debt/Equity | 0.39 | 0.5 | 0.56 | 0.37 | 0.31 | 0.25 | 0.26 | |
Debt/TotalCap | 0.28 | 0.33 | 0.36 | 0.27 | 0.24 | 0.2 | 0.2 | |
Debt/EBITDA | 3.26 | 8.11 | 3.96 | 1.53 | 1.11 | 1.02 | 1.78 | |
EBITDA/IntExps | 118.18 | 8.24 | 29.5 | 152.59 | 89.84 | 63.36 | 36.42 | 341.99 |
RATING & BTO MATRIX | ||||||
---|---|---|---|---|---|---|
Benchmark to Others : | ||||||
A Exceptional | ||||||
B Excellent | ||||||
C Very Good | ||||||
D Good | ||||||
E Fair | ||||||
F Poor | ![]() |
|||||
RATING | ||||||
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
MARKET CAPITALIZATION | ||
Listed Share | 448.000.000 | |
Price | Rp. 3.460 | |
Capitalization | Rp. 1.550 B. | |
OWNERSHIP | ||
Listing Date : | ||
Lokal 8,63 % | Asing 16,53 % | Lainnya 74,84 % |
RATING FUNDAMENTAL | ||
---|---|---|
Rating EPS | 3 | |
Rating ROA | 1 | |
Rating EQUITY | 1 | |
Rating ROE | 1 | |
Rating DER | 5 | |
Rating TOTAL | 2 |
![]() | MERK - Merck Tbk. | MERK - Merck Tbk. | MERK - Merck Tbk. | |
Sector | : | Healthcare | ||
Sub Sector | : | Pharmaceuticals and Health Care Research | ||
Industry | : | Pharmaceuticals | ||
Sub Industry | : | Pharmaceuticals | ||
Index (5) | : | COMPOSITE, IDXHEALTH, ISSI, IDXSMC-COM, DBX | ||
Index (5) | : | COMPOSITE, IDXHEALTH, ISSI, IDXSMC-COM, DBX | ||
Board | : | 5 Index COMPOSITE, IDXHEALTH, ISSI, IDXSMC-COM, DBX | ||
Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
Pre Opening | : | Saham dapat diperdagangan melalui sesi Pre-opening | ||
Corporate Action | : | - | ||
TIME PERIOD : 07-02-2025 | |||
Close | 3460 | Prev Close | 3500 |
Change | -40 (-1.2%) | Range | 3410-3480 |
Bid | 3410 | Offer | 3460 |
Bid Volume | 400 | Offer Volume | 100 |
Frequency | 30 | Value Rp.: 73.910.000 |
EARNING PER SHARE (% PRICE) | |||||
---|---|---|---|---|---|
Benchmark to Others : | |||||
A Exceptional | |||||
B Excellent | |||||
C Very Good | |||||
D Good | |||||
E Fair | |||||
F Poor | ![]() |
||||
Percent (%) of Price |
≤ 0 |
0-1.05 | 1.05-2.3 | 2.3-4.23 | > 4.23 |
RATING & BTO MATRIX | ||||||
---|---|---|---|---|---|---|
Benchmark to Others : | ||||||
A Exceptional | ||||||
B Excellent | ||||||
C Very Good | ||||||
D Good | ||||||
E Fair | ||||||
F Poor | ![]() |
|||||
RATING | ||||||
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING | 0 | 1 | 2 | 3 | 4 | 5 |